Stocks making the biggest moves in the premarket: Gilead Sciences, Starbucks, BP, Coty & more

Take a look at some of the biggest movers in the premarket:

Gilead Sciences (GILD) – Gilead set pricing for its remdesivir anti-viral Covid-19 treatment, with developed-world governments paying $390 per dose and privately insured patients being charged $520 per dose.

Intercept Pharmaceuticals (ICPT) – The Food and Drug Administration did not approve the company’s treatment for obesity-linked liver disease. Intercept said it would meet with the FDA to discuss possible paths to approval.

Starbucks (SBUX), Coca-Cola (KO) – Starbucks and Coca-Cola both announced pauses in social media ads, in the latest actions against hate speech on platforms like Facebook (FB) and Twitter (TWTR). Similar actions were announced by spirits producer Diageo (DEO) and chocolate maker Hershey (HSY).


Read Story